| Characteristic | HIV-, N = 201 | HIV+ART+, N = 561 | p-value2 |
|---|---|---|---|
| cotrimoxazole | 0.2 | ||
| Susceptible | 3 (15%) | 3 (5.4%) | |
| non-susceptible | 17 (85%) | 53 (95%) | |
| tetracycline | 0.081 | ||
| Susceptible | 8 (40%) | 35 (62%) | |
| non-susceptible | 12 (60%) | 21 (38%) | |
| oxacillin | 0.6 | ||
| Susceptible | 9 (45%) | 32 (57%) | |
| Intermediate | 2 (10%) | 6 (11%) | |
| Resistant | 9 (45%) | 18 (32%) | |
| chloramphenicol | >0.9 | ||
| Susceptible | 19 (95%) | 54 (96%) | |
| non-susceptible | 1 (5.0%) | 2 (3.6%) | |
| erythromycin | 0.2 | ||
| Susceptible | 11 (55%) | 40 (71%) | |
| non-susceptible | 9 (45%) | 16 (29%) | |
| age | 28 (25, 35) | 33 (26, 39) | 0.2 |
| Unknown | 0 | 3 | |
| sex | 0.5 | ||
| Male | 6 (30%) | 20 (38%) | |
| Female | 14 (70%) | 33 (62%) | |
| Unknown | 0 | 3 | |
| MDR | 0.13 | ||
| non | 11 (55%) | 41 (73%) | |
| MDR | 9 (45%) | 15 (27%) | |
|
1
n (%); Median (IQR)
2
Fisher's exact test; Pearson's Chi-squared test; Wilcoxon rank sum test
|
|||